WeightWatchers will file for bankruptcy in the coming weeks after finally negotiating a deal on its $1.6 billion of debt.

The rise of weight-loss drugs like Ozempic and Wegovy have upended WeightWatchers business model, which was based around selling low-calorie foods and diet advice to overweight people.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...

You can use Wegovy (semaglutide) as long as you need for weight loss and weight management. You can continue taking Wegovy if you and your doctor determine that Wegovy is safe for you and you can ...

At a House Oversight Committee hearing on Wednesday, Rep. Robert Garcia (D-CA) called Rep. Marjorie Taylor Greene (R-GA) "an anti-vax conspiracy theorist." Fuel your success with Forbes.

The most popular GLP-1 agent today is semaglutide, the active ingredient in type 2 diabetes medication Ozempic and the higher-dose obesity drug Wegovy. Semaglutide and newer GLP-1 drugs help ...

They said that semaglutide, which is sold under the brand names Ozempic and Wegovy, was “statistically significantly associated with a decreased risk” of dementia. Semaglutide was initially ...

This was a mistake. These drugs, like Ozempic and Wegovy, can be a game changer. I know firsthand. In July, I was prescribed a drug called Mounjaro. As a stroke survivor, I was interested in ...

Novo Nordisk is considering launching its weight loss injection Wegovy in India sooner than planned to better challenge U.S. rival Eli Lilly, Reuters reports, citing unnamed sources. --The Danish ...